CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...
Sirona is a dual-polymer hydrogel pill that expands in the stomach, reducing appetite. Participants consumed 400 fewer ...
Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients completing treatment in the ongoing ...
Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with ...
Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...
Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...
NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.
The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation phase and the start of the cohort expansion ...
To help HCPs find reliable online answers about medicines, Datapharm collaborated with Medical Information Leaders in Europe ...
Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS.
At its core, the regulation aims to improve transparency and accountability in clinical trials across Europe. For ...
To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has adopted Netcall’s Liberty for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results